246 related articles for article (PubMed ID: 24944761)
1. Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity.
Vuilleumier N; Montecucco F; Hartley O
World J Cardiol; 2014 May; 6(5):314-26. PubMed ID: 24944761
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.
Teixeira PC; Cutler P; Vuilleumier N
Clin Dev Immunol; 2012; 2012():868251. PubMed ID: 23227091
[TBL] [Abstract][Full Text] [Related]
3. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
Bridge SH; Pagano S; Jones M; Foster GR; Neely D; Vuilleumier N; Bassendine MF
Hepatol Int; 2018 Jan; 12(1):17-25. PubMed ID: 29423541
[TBL] [Abstract][Full Text] [Related]
5. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Satta N; Frias MA; Vuilleumier N; Pagano S
Curr Pharm Des; 2019; 25(29):3128-3146. PubMed ID: 31470782
[TBL] [Abstract][Full Text] [Related]
6. Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Bastardot F; Hartley O; Montecucco F; Mach F; Waeber G; Vollenweider P; Vuilleumier N
Thromb Haemost; 2016 Sep; 116(4):764-71. PubMed ID: 27384400
[TBL] [Abstract][Full Text] [Related]
7. A role for autoantibodies in atherogenesis.
Iseme RA; McEvoy M; Kelly B; Agnew L; Walker FR; Handley T; Oldmeadow C; Attia J; Boyle M
Cardiovasc Res; 2017 Aug; 113(10):1102-1112. PubMed ID: 28899001
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
[TBL] [Abstract][Full Text] [Related]
9. Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.
Teixeira PC; Ducret A; Ferber P; Gaertner H; Hartley O; Pagano S; Butterfield M; Langen H; Vuilleumier N; Cutler P
J Biol Chem; 2014 Oct; 289(41):28249-59. PubMed ID: 25170076
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein functionality in systemic lupus erythematosus.
Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
12. Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report.
Henson D; Tahhan AS; Nardo D; Quyyumi AA; Venditto VJ
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1884-1892. PubMed ID: 31315438
[TBL] [Abstract][Full Text] [Related]
13. The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
Pagano S; Gaertner H; Cerini F; Mannic T; Satta N; Teixeira PC; Cutler P; Mach F; Vuilleumier N; Hartley O
PLoS One; 2015; 10(7):e0132780. PubMed ID: 26177543
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
[TBL] [Abstract][Full Text] [Related]
15. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to Apolipoprotein A-1 as Independent Predictors of Cardiovascular Mortality in Renal Transplant Recipients.
Anderson JLC; Pagano S; Virzi J; Dullaart RPF; Annema W; Kuipers F; Bakker SJL; Vuilleumier N; Tietge UJF
J Clin Med; 2019 Jun; 8(7):. PubMed ID: 31261925
[TBL] [Abstract][Full Text] [Related]
17. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.
Carbone F; Satta N; Montecucco F; Virzi J; Burger F; Roth A; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Lalive PH; Mach F; Fainardi E; Vuilleumier N
Eur J Clin Invest; 2016 Sep; 46(9):805-17. PubMed ID: 27490973
[TBL] [Abstract][Full Text] [Related]
18. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
20. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
